Alice Récalde

Alice Récalde

Auto-generated profile, based on publicly available information

Alice Récalde

Division of Cardiovascular Medicine, University of Oxford, L6, West Wing, Oxford OX3 9DU, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2016 in Circulation Research
Verified
Journal Article
Open access
Alexios S AntonopoulosAlexios S Antonopoulos
Alexios S Antonopoulos
MMMarios Margaritis
Marios Margaritis
SVSander Verheule
Sander Verheule
ARAlice Recalde
Alice Recalde
FSFabio Sanna
Fabio Sanna
CACharalambos Antoniades
Charalambos Antoniades
Rationale:: Adiponectin has anti-inflammatory effects in experimental models, but its role in the regulation of myocardial redox state in humans is unknown. Although adiponectin is released from epicardial adipose tissue (EpAT), it is unclear whether it exerts any paracrine effects on the human myocardium. Objective:: To explore the cross talk between EpAT-derived adiponectin and myocardial redox state in the human heart. Methods and Results:: EpAT and atrial myocardium were obtained from 306 patients undergoing coronary artery bypass grafting. Functional genetic polymorphisms that increase ADIPOQ expression (encoding adiponectin) led to reduced myocardial nicotinamide adenine dinucleotide phosphate oxidase–derived O 2 − , whereas circulating adiponectin and ADIPOQ expression in EpAT were associated with elevated myocardial O 2 − . In human atrial tissue, we demonstrated that adiponectin suppresses myocardial nicotinamide adenine dinucleotide phosphate oxidase activity, by preventing AMP kinase–mediated translocation of Rac1 and p47 phox from the cytosol to the membranes. Induction of O 2 − production in H9C2 cardiac myocytes led to the release of a transferable factor able to induce peroxisome proliferator-activated receptor-γ–mediated upregulation of ADIPOQ expression in cocultured EpAT. Using a NOX2 transgenic mouse and a pig model of rapid atrial pacing, we found that oxidation products (such as 4-hydroxynonenal) released from the heart trigger peroxisome proliferator-activated receptor-γ–mediated upregulation of ADIPOQ in EpAT. Conclusions:: We demonstrate for the first time in humans that adiponectin directly decreases myocardial nicotinamide adenine dinucleotide phosphate oxidase activity via endocrine or paracrine effects. Adiponectin expression in EpAT is controlled by paracrine effects of oxidation products released from the heart. These effects constitute a novel defense mechanism of the heart against myocardial oxidative stress.

2 June 2009 in Circulation
Verified
Journal Article
Closed access
PDF file
ALAurelie S. Leroyer
Aurelie S. Leroyer
TETéni G. Ebrahimian
Téni G. Ebrahimian
CCClément Cochain
Clément Cochain
ARAlice Récalde
Alice Récalde
OBOlivier Blanc-Brude
Olivier Blanc-Brude
JSJean-Sébastien Silvestre
Jean-Sébastien Silvestre
Background— We hypothesized that microparticles (MPs) released after ischemia are endogenous signals leading to postischemic vasculogenesis. Methods and Results— MPs from mice ischemic hind-limb muscle were detected by electron microscopy 48 hours after unilateral femoral artery ligation as vesicles of 0.1- to 1-μm diameter. After isolation by sequential centrifugation, flow cytometry analyses showed that the annexin V + MP concentration was 3.5-fold higher in ischemic calves than control muscles (1392±406 versus 394±180 annexin V + MPs per 1 mg; P <0.001) and came mainly from endothelial cells (71% of MPs are CD 144+ ). MPs isolated from ischemic muscles induced more potent in vitro bone marrow–mononuclear cell (BM-MNC) differentiation into cells with endothelial phenotype than those isolated from control muscles. MPs isolated from atherosclerotic plaques were ineffective, whereas those isolated from apoptotic or interleukin-1β–activated endothelial cells also promoted BM-MNC differentiation. Interestingly, MPs from ischemic muscles produced more reactive oxygen species and expressed significantly higher levels of NADPH oxidase p47 (6-fold; P <0.05) and p67 subunits (16-fold; P <0.001) than controls, whereas gp91 subunit expression was unchanged. BM-MNC differentiation was reduced by 2-fold with MPs isolated from gp91-deficient animals compared with wild-type mice ( P <0.05). MP effects on postischemic revascularization were then examined in an ischemic hind-limb model. MPs isolated from ischemic muscles were injected into ischemic legs in parallel with venous injection of BM-MNCs. MPs increased the proangiogenic effect of BM-MNC transplantation, and this effect was blunted by gp91 deficiency. In parallel, BM-MNC proangiogenic potential also was reduced in ABCA1 knockout mice with impaired vesiculation. Conclusion— MPs produced during tissue ischemia stimulate progenitor cell differentiation and subsequently promote postnatal neovascularization.

21 January 2019 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
THThomas Hof
Thomas Hof
SCSébastien Chaigne
Sébastien Chaigne
ARAlice Récalde
Alice Récalde
LSLaurent Sallé
Laurent Sallé
Fabien BretteFabien Brette
Fabien Brette
RGRomain Guinamard
Romain Guinamard

6 October 2009 in Circulation
Verified
Journal Article
Closed access
PDF file
YZYasmine Zouggari
Yasmine Zouggari
HAHafid Ait-Oufella
Hafid Ait-Oufella
LWLudovic Waeckel
Ludovic Waeckel
JVJosé Vilar
José Vilar
CLCélIne Loinard
CélIne Loinard
JSJean-Sébastien Silvestre
Jean-Sébastien Silvestre
Background— CD4 + and CD8 + T lymphocytes are key regulators of postischemic neovascularization. T-cell activation is promoted by 2 major costimulatory signalings, the B7/CD28 and CD40–CD40 ligand pathways. Interestingly, CD28 interactions with the structurally related ligands B7-1 and B7-2 are also required for the generation and homeostasis of CD4 + CD25 + regulatory T cells (Treg cells), which play a critical role in the suppression of immune responses and the control of T-cell homeostasis. We hypothesized that Treg cell activation may modulate the immunoinflammatory response to ischemic injury, leading to alteration of postischemic vessel growth. Methods and Results— Ischemia was induced by right femoral artery ligation in CD28-, B7-1/2–, or CD40-deficient mice (n=10 per group). CD40 deficiency led to a significant reduction in the postischemic inflammatory response and vessel growth. In contrast, at day 21 after ischemia, angiographic score, foot perfusion, and capillary density were increased by 2.0-, 1.2-, and 1.8-fold, respectively, in CD28-deficient mice, which showed a profound reduction in the number of Treg cells compared with controls. Similarly, disruption of B7-1/2 signaling or anti-CD25 treatment and subsequent Treg deletion significantly enhanced postischemic neovascularization. These effects were associated with enhanced accumulation of CD3-positive T cells and Mac-3–positive macrophages in the ischemic leg. Conversely, treatment of CD28 −/− mice with the nonmitogenic anti-CD3 monoclonal antibody enhanced the number of endogenous Treg cells and led to a significant reduction of the postischemic inflammatory response and neovascularization. Finally, coadministration of Treg cells and CD28 −/− splenocytes in Rag1 −/− mice with hindlimb ischemia abrogated the CD28 −/− splenocyte-induced activation of the inflammatory response and neovascularization. Conclusion— Treg cell response modulates postischemic neovascularization.

1 September 2012 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
CCClément Cochain
Clément Cochain
CAConstance Auvynet
Constance Auvynet
LPLucie Poupel
Lucie Poupel
JVJosé Vilar
José Vilar
EDEdouard Dumeau
Edouard Dumeau
JSJean-Sébastien Silvestre
Jean-Sébastien Silvestre
Objective—: Leukocyte infiltration in ischemic areas is a hallmark of myocardial infarction, and overwhelming infiltration of innate immune cells has been shown to promote adverse remodeling and cardiac rupture. Recruitment of inflammatory cells in the ischemic heart depends highly on the family of CC-chemokines and their receptors. Here, we hypothesized that the chemokine decoy receptor D6, which specifically binds and scavenges inflammatory CC-chemokines, might limit inflammation and adverse cardiac remodeling after infarction. Methods and Results—: D6 was expressed in human and murine infarcted myocardium. In a murine model of myocardial infarction, D6 deficiency led to increased chemokine (C-C motif) ligand 2 and chemokine (C-C motif) ligand 3 levels in the ischemic heart. D6-deficient (D6 −/−) infarcts displayed increased infiltration of pathogenic neutrophils and Ly6Chi monocytes, associated with strong matrix metalloproteinase-9 and matrix metalloproteinase-2 activities in the ischemic heart. D6 −/− mice were cardiac rupture prone after myocardial infarction, and functional analysis revealed that D6 −/− hearts had features of adverse remodeling with left ventricle dilation and reduced ejection fraction. Bone marrow chimera experiments showed that leukocyte-borne D6 had no role in this setting, and that leukocyte-specific chemokine (C-C motif) receptor 2 deficiency rescued the adverse phenotype observed in D6 −/− mice. Conclusion—: We show for the first time that the chemokine decoy receptor D6 limits CC-chemokine–dependent pathogenic inflammation and is required for adequate cardiac remodeling after myocardial infarction.

25 May 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SRSvetlana N. Reilly
Svetlana N. Reilly
XLXing Liu
Xing Liu
RCRicardo Carnicer
Ricardo Carnicer
ARAlice Recalde
Alice Recalde
AMAnna Muszkiewicz
Anna Muszkiewicz
BCBarbara Casadei
Barbara Casadei
Atrial microRNA-31 up-regulation causes dystrophin and nNOS depletion, which in turn contributes to the electrical phenotype of atrial fibrillation.